Subsidiaries - Univentis Medicare Limited

Sharon Bio-Medicine Limited

API Manufacturing Finished Dosage Forms Toxicology Services Global R&D

Sharon Bio-Medicine Limited is a prominent Indian pharmaceutical company that has evolved from a manufacturer of intermediates and actives into a comprehensive provider of pharmaceutical products and services. Certified by major global regulatory agencies, Sharon Bio-Medicine ensures premium quality across its worldwide operations.

The Evolution of Excellence

Sharon Bio-Medicine Limited has built a legacy of trust and innovation. Our mission is to deliver high-quality healthcare solutions through advanced technology and global regulatory compliance. We leverage specialized technical expertise in complex chemistries like Alkylation, Friedel-Crafts, Grignard, and Nitration to solve modern medical challenges.

Our integrated model seamlessly connects the development of Active Pharmaceutical Ingredients (APIs) with our massive formulation capabilities, ensuring a robust supply chain for life-saving drugs across major markets including the US, EU, Canada, and Australia.

Quick Information

CIN U24110MH1989PLC052251

Corporate Office Unit No. 1513, Satra Plaza, Sector 19D, Vashi, Navi Mumbai, India - 400703

Registered Office (API) Plot No L6, Taloja M.I.D.C, Dist Raigad, Navi Mumbai, India - 410208

Dehradun Unit Khsara No- 1027/28/30/37, Central Hope Town Selaqui, Industrial Area, Dehradun, Uttarakhand

Email info@sharonbio.com | lab@sa-ford.com

Specialized Service Divisions

International-standard pharmaceutical services across the value chain.

Toxicology Services

GLP-certified division (Sa-FORD) offering international-standard studies as per OECD, EPA, ICH, and ISO regulations.

R&D & Process Development

State-of-the-art labs for chemistry and analytical development supported by cGMP-compliant Pilot plants.

Dosage Form Development

Expertise in developing Tablets and Capsules, including modified-release products and global technology transfers.

API Facility (Taloja)

Multiproduct facility with 8 blocks approved by USFDA, EU-GMP, and KFDA for complex technical chemistries.

Formulation (Dehradun)

High-capacity plant (3,000M Tablets annually) approved by UK-MHRA, USFDA, and Health Canada.

Quality Assurance

Continuous monitoring and compliance with the most rigorous global pharmaceutical regulatory standards.

Why This Subsidiary Matters

Global Approvals

Certified by USFDA, EU-GMP, UK-MHRA, and TGA Australia, representing the gold standard in pharmaceutical safety and quality.

Integrated Model

A proprietary finished dosage model combined with in-house API manufacturing creates a highly efficient and secure production ecosystem.

Manufacturing Strength

Massive infrastructure with over 50 dedicated AHUs and a capacity of over 3,400 million dosage units annually.

Our Subsidiaries